Other Publications
-
September 21, 2018 ACCEL Technology Platform – CAR TCR Summit 2018 -
August 31, 2018 FOCIS (Federation of Clinical Immunology Societies) 2018 Poster -
November 1, 2017 Bay Area's AvidBiotics Splits Into Two Biotech Companies
Press Releases
-
December 26, 2019 Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc. -
October 24, 2019 Xyphos Biosciences and Gladstone Institutes Announce Publication Demonstrating convertibleCAR® Cells and Bispecific Broadly Neutralizing Antibodies Reduce Latent HIV Reservoir -
April 16, 2019 Key Patent Issued for Xyphos Biosciences’ ACCEL™ Technology Platform -
October 18, 2018 The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment -
July 3, 2018 Xyphos Biosciences Names Thorsten Melcher, Ph.D., as Chief Business Officer